个人及工作简历
2012年肿瘤学博士毕业，留西安交通大学第二附属医院肿瘤科工作，从事肿瘤外科工作近10年，先后任住院医师，主治医师/助理研究员，副主任医师/副研究员，主要临床方向：乳腺良性疾病微创手术，乳腺癌以及乳腺整形手术。
科研领域（方向）
恶性肿瘤侵袭转移及治疗耐药分子机制的基础研究
科研项目
主持国家自然科学基金2项，青年基金项目已经结题，面上基金项目在研，累计科研经费接近90万。
学术科研成果
[1] Diao Y, Ma XB, Min WL, Lin S, Kang HF, Dai ZJ, Wang XJ, Zhao Y. Dasatinib promotes paclitaxel-induced necroptosis in lung adenocarcinoma with phosphorylated caspase-8 by c-Src[J]. Cancer Letters, 2016, 379(1): 12-23.
[2] Zhao Y, Dai ZJ, Min WL, Sui X, Kang HF, Zhang YF, Ren H, Wang XJ*. Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus: A Phase III Randomized Trial[J]. Journal of Thoracic Oncology, 2015, 10(9): 1349-1356.
[3] Zhou Linghui#, Zhao Yang#, Zheng Yi#, Wang Meng, Tian Tian, Lin Shuai, Hao Qian, Xu Peng, Deng Yujiao, Li Na, Wu Ying, Yang Tielin, Kang Huafeng*, Dai Zhijun*. The Prognostic Value of the Number of Negative Lymph Nodes Combined with Positive Lymph Nodes in Esophageal Cancer Patients: A Propensity-Matched Analysis[J]. Annals of Surgical Oncology, 2020, 27(6): 2042-2050.
[4] Zhao Y, Sui X, Ren H*. From Procaspase-8 to Caspase-8: Revisiting Structural Functions of Caspase-8 [J]. Journal of Cellular Physiology, 2010, 225(2):316-320.
[5] Peng Xu#, Zhao Y#, Kang Liu#, Shuai Lin, Xinghan Liu, Meng Wang, Pengtao Yang, Tian Tian, Yuyao Zhu, Zhijun Dai*. Prognostic role and clinical signicance of trophoblast cell surface antigen 2 in various carcinomas[J]. Cancer Management and Research, 2017, 9: 821-837. (共一作者)
[6] Zhao Y#, Dai C#, Wang Wang, Kang HF, Lin S, Yang PT, Liu XH, Liu K, Xu P, Zheng Y, Li SL, Dai ZJ*. Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) overexpression in colorectal cancer: a meta-analysis[J]. Oncotarget, 2016, 7(39): 62966-62975. (共一作者)
[7] Zhao Y#, Xu P#, Kang HF, Lin S, Wang M, Yang PT, Dai C, Liu XH, Liu K, Zheng Y, Dai ZJ*. Prognostic nutritional index as a prognostic biomarker for survival in digestive system carcinomas[J]. Oncotarget, 2016, 7(52): 86573-86583. (共一作者)
[8] Zhao Y#, Diao Y#, Wang XJ, Lin S, Wang M, Kang HF, Yang PT, Dai C, Liu XH, Liu K, Li SL, Zhu YY, Dai ZJ*. Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the chinese population[J]. Oncotarget, 2016, 7(36): 58174-58180. (共一作者)
[9] Min Weili, He Chenyang, Zhang Shuqun, Zhao Yang. c-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma[J]. Fronteriors in Oncology, 2021, 22(11): 602900.
[10] Zhang YF, Sun LZ, Gao X, Guo AN, Diao Y, Zhao Y. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma[J]. BMC Cancer, 2019, 19(2): 670-677.
学会任职
中华医学会整合医学分会青年委员会 委员
陕西省抗癌协会乳腺癌专业委员会 委员
陕西省预防保健协会乳腺转移委员会 委员
陕西省抗癌协会肺癌专业青年委员会 常委
西安市长安医学会甲乳外科专业委员会 副主委
IASLC 会员
联系方式
联系电话：17316630883 电子邮箱：szhaoy@126.com
